zelapar (selegiline HCl) Orally Disintegrating Tablets
Patient Resources
For Healthcare Professionals

Web Resources for People with Parkinson’s Disease.

Here are links to a wealth of information and support that PD patients and caregivers may find valuable.

The links below are not controlled by Valeant Pharmaceuticals International or its affiliates. Valeant Pharmaceuticals International assumes no responsibility or liability for the views, content or accuracy of this information, nor does it endorse any products that may be advertised or noted on these websites.

Non-profit Organizations

www.pdf.org
Parkinson’s Disease Foundation

www.apdaparkinson.org
American Parkinson Disease Association, Inc.

www.michaeljfox.org
The Michael J. Fox Foundation for Parkinson's Research

www.parkinson.org
National Parkinson Foundation

www.parkinsonalliance.org
The Parkinson Alliance

www.parkinsonsinstitute.org
The Parkinson’s institute

Independent Regional Advocacy Groups

www.dallasareaparkinson.org
Dallas Area Parkinsonism Society

www.hapsonline.org
Houston Area Parkinson Society

www.maineparkinsonsociety.org
Maine Parkinson Society

www.parkinsonsmi.org
Michigan Parkinson Foundation

www.nwpf.org
Northwest Parkinson’s Foundation

www.parkinsonrockies.org
Parkinson Association of the Rockies

www.parkinsonsresource.org
Parkinson’s Resource Organization

www.parkinsonsresources.org
Parkinson’s Resources of Oregon

www.cureparkinsons.org
Take Charge! Cure Parkinson’s, Inc.

Political Advocacy

www.camradvocacy.org
Coalition for the Advancement
of Medical Research

www.grassrootsconnection.com
Grassroots Connection

www.kaisernetwork.org/
Kaiser Network Daily Health Policy Report

www.parkinsonsaction.org
Parkinson’s Action Network (PAN)

Web Directories

www.geocities.com/murraycharters
Parkinson’s Resources on the Web

www.pdindex.org
PD Index

Clinical Trials

www.pdtrials.org
Advancing Parkinson’s Therapies (APT)
Clinical Trials Website

www.centerwatch.com
Centerwatch

www.clinicaltrials.gov
National Institutes of Health

www.pdpipeline.org
Parkinson Pipeline Project

www.parkinson-study-group.org
Parkinson Study Group (PSG)

Medical Information Sites

www.intelihealth.com
Aetna Intelihealth

www.cumc.columbia.edu/hs/health.html
The Complete Home Medical Guide

www.healingwell.com
HealingWell.com

www.nlm.nih.gov/
Medline plus

www.medscape.com
Medscape

www.neurologychannel.com
Neurology Channel

www.parkinsonscontrol.com
Parkinson’s Control

Pdweb.mgh.Harvard.edu
The Parkinson’s Web

www.rxlist.com
RxList

www.webmd.com
WebMD Parkinson’s Disease Condition Center

Science News

www.eurekalert.org
EurekAlert!

www.ninds.nih.gov/index.htm
National Institute of Neurological Disorders
and Stroke

www.sciencedaily.com
ScienceDaily

www.wemove.org
WE MOVE

Listservs (online discussion groups)

www.braintalk.org
Brain Talk Communities

www.parkinsons-information-
exchange-network-online.com

Parkinson’s Information Exchange Network Online

Resources and Services

www.aarp.org
AARP

www.aoa.dhhs.gov
Administration on Aging

www.medicare.gov
Medicare

www.patientadvocate.org
The patient Advocate Foundation

Support and Therapy

www.lsvt.org
The Lsvt® (Lee Silverman Voice Treatment) Foundation

www.medicalert.org
MedicAlert

www.mentalhelp.net/selfhelp/
Self-Help Group Sourcebook Online

www.yopa.org
Young Onset Parkinson’s Association

Caregivers

www.caregiver.com
Caregiver Media Group

www.nfcacares.org
National Family Caregivers Association

www.parkinsonseducator.com
Parkinson’s Training

» About Zelapar
» Understanding PD
» Parkinson’s Caregiver
» For Healthcare Professionals
» Doctor Visit Checklist

 

Important Safety Information

Zelapar® is a special formulation of the drug selegiline that adds more active hours for patients with Parkinson’s disease (PD). Doctors may recommend adding Zelapar to levodopa/carbidopa treatment when patients are experiencing a reduced response to this therapy.

Do not take Zelapar if you are allergic to selegiline or any of the other ingredients in Zelapar. Zelapar should not be taken with certain medications. Discuss any medicine you are taking with your doctor. Zelapar should not be taken with meperedine (DEMEROL®) or other opiods. Rare cases of high blood pressure have been associated with taking conventional forms of selegiline with foods containing tyramine. Zelapar may cause you to have low blood pressure when you stand (this is more common in older patients than in younger ones). If you are pregnant, you must speak to your doctor about whether to take Zelapar. (Zelapar should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.) Do not take more than 2 tablets (2.5 mg) a day.

Zelapar was very well tolerated in clinical trials. The most commonly reported side effects were dizziness, nausea, pain, headache, trouble sleeping, runny nose, involuntary movements, back pain, skin disorders, mouth inflammation, and upper stomach pain. In addition, 5.2% of patients discontinued Zelapar therapy due to side effects (vs. 1% with placebo).

You may need your levodopa dose reduced after starting Zelapar therapy. Be sure to speak with your doctor if you experience any side effects.

Please see accompanying complete prescribing information.

Demerol® is a registered trademark of the Sanofi-Aventis Group. Prozac® is a registered trademark of Eli Lilly and Company.
Valeant Pharmaceuticals